|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Children's Healthcare of Atlanta |
|---|---|
| Information provided by: | Children's Healthcare of Atlanta |
| ClinicalTrials.gov Identifier: | NCT00366314 |
Purpose
The purpose of this study is to quantify and analyze the line accesses for each of the 3 participating ICUs.
The hypothesis is that the CICU will have a significantly higher number of line accesses than the other units. Analyzing the data will assist the researchers in identifying best practices and ultimately, reduce the BSI rate in the CICU.
| Condition |
|---|
|
Congenital Disorders |
| Study Type: | Observational |
| Study Design: | Natural History, Longitudinal, Defined Population, Retrospective Study |
| Official Title: | Frequency of Accessing Central Lines for Blood Samples and Medication Administration: A Comparison Between CICU, PICU and NICU |
Eligibility| Ages Eligible for Study: | up to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Georgia | |
| Children's Healthcare of Atlanta | |
| Atlanta, Georgia, United States, 30322 | |
| Principal Investigator: | Nicole M Jarrell, RNC, MSN | Children's Healthcare of Atlanta |
More Information
| Study ID Numbers: | 06-142 |
| Study First Received: | August 17, 2006 |
| Last Updated: | June 12, 2007 |
| ClinicalTrials.gov Identifier: | NCT00366314 |
| Health Authority: | United States: Food and Drug Administration |
|
Blood samples Medication administration CICU PICU NICU |
